Contact

Bryan Hughes’ Article Featured in Medical Product Outsourcing Magazine: Will a Wave of Medtech Spinoffs Hurt the Supply Base?

April 13, 2023

Bryan Hughes, Managing Director and lead of PMCF’s Healthcare team, authored the Medical Product Outsourcing article “Will a Wave of Medtech Spinoffs Hurt the Supply Base?” In the publication, he shared his thoughts on whether or not the flurry of med tech spinoff transactions will create further dislocation across the supply chain in the near term.

“In the near term, a spinoff’s strategic and financial benefits must outweigh dis-synergies and management distractions in order to create shareholder value,” commented Bryan. “While the strategic and financial benefits will impact suppliers longer-term, management distractions and focus of resources on carve-out mechanics likely has the greatest impact today.”

Bryan provided additional context on how several med tech companies, including GE Healthcare and Zimmer ZimVie, were able to achieve successful spinouts starting with a well-defined plan to achieve a specific growth rate and hit certain EBITDA or operating income targets.

Excerpt:

Across all U.S. industries the number of announced spinoffs surged by more than 30% last year. In each case, company management framed the spinoffs or divestitures as the logical conclusion of ongoing portfolio optimization initiatives. As COVID-19 continues to transition from pandemic to endemic, many medical device companies have experienced below-average or slowing growth and as a consequence, investors have shifted their focus from growth to profitability.

Read the full article: Will a Wave of Medtech Spinoffs Hurt the Supply Base?

 

Subscribe

More Articles

Distribution M&A remains active in 2026, but buyers are becoming more selective about the businesses they pursue and the attributes that warrant premium valuations.

Read More

The building products sector continues to consolidate as strategic acquirers and private equity investors pursue businesses with differentiated products, strong market positions, and exposure to long-term growth drivers. But the companies creating the most value aren’t always the biggest.

Read More

Packaging M&A continues to attract interest from strategic buyers and private equity investors, even as rising input costs, sustainability requirements, and broader economic uncertainty shape transaction decisions.

Read More

While MedTech M&A activity has slowed from prior peaks, buyers remain active for the right opportunities.

Read More

While Transportation and Logistics M&A activity has moderated from the record-setting pace seen in 2021 and 2022, there’s increasing optimism about what lies ahead.

Read More